What is new in ACC/AHA 2017 focused update of valvular heart disease guidelines

Kaynakça (6)

1. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Fleisher LA, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ ACC Guideline for the management of patients with valvular heart disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2017 Mar 15. Epub ahead of print
2. Gürsoy OM, Karakoyun S, Kalçık M, Özkan M. The incremental value of RT three-dimensional TEE in the evaluation of prosthetic mitral valve ring thrombosis complicated with thromboembolism. Echocardiography 2013; 30: E198-201
3. Gündüz S, Özkan M, Kalçik M, Gürsoy OM, Astarcioğlu MA, Karakoyun S, et al. Sixty-Four-Section Cardiac Computed Tomography in Mechanical Prosthetic Heart Valve Dysfunction: Thrombus or Pannus. Circ Cardiovasc Imaging 2015; 8: e003246
4. Özkan M, Gündüz S, Biteker M, Astarcıoğlu MA, Çevik C, Kaynak E, et al. Comparison of different TEE-guided thrombolytic regimens for prosthetic valve thrombosis: The TROIA Trial. JACC Cardiovasc Imaging 2013; 6: 206-16
5. Özkan M, Çakal B, Karakoyun S, Gürsoy OM, Çevik C, Kalcık M, et al. Thrombolytic therapy for the treatment of prosthetic heart valve thrombosis in pregnancy with low-dose, slow infusion of tissuetype plasminogen activator. Circulation 2013; 128: 532-40
6. Özkan M, Gündüz S, Gürsoy OM, Karakoyun S, Astarcıoğlu MA, Kalçık M, et al. A novel strategy in the management of PROsthetic Mechanical valve Thrombosis and the prEdictors of outcomE: the Ultra-slow PROMETEE trial. Am Heart J 2015; 170: 409-18.